Results 31 to 40 of about 49,191 (297)

WAO guideline for the management of hereditary angioedema [PDF]

, 2012
Hereditary Angioedema (HAE) is a rare disease and for this reason proper diagnosis and appropriate therapy are often unknown or not available for physicians and other health care providers.
Aygören-Pürsün, Emel, Bork, Konrad, Bowen, Tom, Boysen, Henrik B., Craig, Timothy, Farkas, Henriette, Grumach, Anete, Katelaris, Constance H., Lockey, Richard, Longhurst, Hilary, Lumry, William, Magerl, Markus, Martinez-Saguer, Immaculada, Maurer, Marcus, Nast, Alexander, Pawankar, Ruby, Ritchie, Bruce, Zuraw, Bruce   +17 more
core   +1 more source

Urticaria and mimickers of urticaria

Frontiers in Allergy, 2023
Urticaria is a common skin condition encountered across various specialties in medicine, especially in dermatology and allergy/immunology practice. It has a heterogeneous presentation hence it is unsurprising that many skin conditions may be confused ...
Jie Shen Fok, Jie Shen Fok, Jie Shen Fok, Constance H. Katelaris, Constance H. Katelaris   +4 more
doaj   +1 more source

Cost Utility of Omalizumab Compared with Standard of Care for the Treatment of Chronic Spontaneous Urticaria. [PDF]

, 2016
BACKGROUND: Chronic spontaneous urticaria (CSU) negatively impacts patient quality of life and productivity and is associated with considerable indirect costs to society.
Agirrezabal, I., Alexopoulos, S.T., Balp, M.M., Brennan, A., Graham, J., Griffiths, M., Halliday, A., McBride, D., Stull, D., Zuberbier, T.   +9 more
core   +1 more source

Clinical efficacy of omalizumab in chronic spontaneous urticaria is associated with a reduction of FcεRI-positive cells in the skin [PDF]

, 2017
Background. Treatment with omalizumab, a humanized recombinant monoclonal anti-IgE antibody, results in clinical efficacy in patients with Chronic Spontaneous Urticaria (CSU). The mechanism of action of omalizumab in CSU has not been elucidated in detail.
Ashton-Chess, Joanna, Bauer, Andrea, Brehler, Randolf, Canvin, Janice, Erpenbeck, Veit J., Georgiou, Panayiotis, Gericke, Janine, Hillenbrand, Rainer, Jarvis, Philip, Kangas, Michael, Maurer, Marcus, Metz, Martin, Staubach, Petra   +12 more
core   +1 more source

Transient improvement of urticaria induces poor adherence as assessed by Morisky Medication Adherence Scale-8. [PDF]

, 2015
Poor adherence to medication is a major public health challenge. Here, we aimed to determine the adherence to oral and topical medications and to analyze underlying associated factors using the translated Japanese version of Morisky Medication Adherence ...
Abe, Masatoshi, Abe, Shinya, Furue, Masutaka, Hagihara, Akihito, Hiragun, Takaaki, Imafuku, Shinichi, Inomata, Naoko, Kaneko, Sakae, Katoh, Norito, Kitami, Yuki, Kobayashi, Miwa, Masuda, Koji, Morisky, Donald E, Murota, Hiroyuki, Onozuka, Daisuke, Saeki, Hidehisa, Shintani, Yoichi, Sugaya, Makoto, Takeuchi, Satoshi, Tanioka, Miki, Tsunemi, Yuichiro   +20 more
core  

H1-antihistamines for chronic spontaneous urticaria [PDF]

, 2014
Background Chronic spontaneous urticaria (CSU) is characterised by the development of crops of red, itchy, raised weals or hives with no identifiable external cause. Objectives To assess the effects of H1-antihistamines for CSU.
Abushareeah, Alomar, Alomar, Andri, Anon, Anonymous, Anonymous, Anonymous (Wan-Qing, Arendt, Atsushi, Audı´cana, Bakos, Baraf, Beck, Belaich, Bernd, Bernstein, Bian, Blanca Gomez, Bleehen, Bloom, Boggs, Breneman, Breneman, Bronsky, Brostoff, Brunet, Cainelli, Camarasa, Cassano, Cauwenberge, Champion, Charlesworth, Chatterjee, Chen, Church, Church, Commens, Cook, Dakhale, Degonda, Demera, Devillier, Devillier, Dhurandhar, Diller, Dockx, Dubertret, Dubertret, DuBuske, Fan, Farshchain, Fedorowicz, Feng, Ferguson, Finn, Finn, Fox, Gaig, Gale, Garavaglia, Ge, Giannetti, Gimenez-Arnau, Go, Godse, Godse, Goh, Gong, Gonzalez-Morales, Grant, Grattan, Grattan, Greaves, Greene, Grob, Grob, Grob, Gu, Guaglianone, Guerra, Guo, Guo, Guo, Hair, Hamerlinck, Hampel, Hampel, Han, Handa, Hao, Harvey, Hatano, Hein, Hellgren, Hjorth, Holgate, Honsinger, Hoxha, Humphreys, Ishibashi, Ishibashi, Ishibashi, Ishibashi, Ishibashi, Ishibashi, Isola, James, Jauregui, Jia, Jolliffe, Joost, Juhlin, Juhlin, Juhlin, Jyothi, Kalimo, Kalis, Kalis, Kalivas, Kameyoshi, Kamide, Kaplan, Kaplan, Kapp, Kavosh, Kawada, Kawashima, Khalaf, Kietzmann, Kint, Kukita, Kukita, Kukita, Kukita, Kukita, Kukita, Kukita, Kuokkanen, Kuokkanen, Kuokkanen, Lambert, Lambert, Lan, Leyh, Leynadier, Li, Liu, Liu, Liu, Locci, Lorenzo, Magerl, Magerl, Marks, Maurer, Maurer, Maurer, Meloy, Monroe, Monroe, Monroe, Monroe, Monroe, Monroe, Monroe, Monteseirin Mateo, Mora, Nakayama, Nelson, Nettis, Nettis, Neumann, Nishiyama, Nolen, Nsouli, Ormerod, Ortonne, Ortonne, Paul, Paul, Paul, Paul, Paul, Paul, Paul, Paul, Pavic, Peyri, Phanuphak, Pons-Guiraud, Prenner, Presch, Ring, Rosa, Saihan, Salisbury, Salmun, Salo, Sanchez-Borges, Sanchez-Borges, Sener, Shah, Shareeah, Shereff, Sim-Davis, Simons, Singh, Sobye, Spector, Spector, Staevska, Staevska, Staevska, Sussman, Tanizaki, Taskapan, Thompson, Thompson, Thompson, Tilles, Valsecchi, Vijay, Wang, Wang, Wang, Warin, Weitgasser, Weller, Witte, Wolfram, Wozel, Wu, Wu, Yamada, Yin, Yin, Youngchaiyud, Zabel, Zhang, Zhang, Zhang, Zhang, Zhang, Zhao, Zhi, Zhou, Zhu, Zou, Zuberbier, Zuberbier   +250 more
core   +1 more source

Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Belimumab in Pediatric Patients With Systemic Lupus Erythematosus: A Multicenter, Open‐Label Trial

Arthritis Care &Research, EarlyView.
Objective This study aimed to characterize the pharmacokinetics, pharmacodynamics, safety, and exploratory efficacy of subcutaneous belimumab in pediatric patients with active systemic lupus erythematosus (SLE) receiving standard therapy. Methods This single‐arm, multicenter, open‐label trial (GSK study 200908; ClinicalTrials.gov identifier ...
Hermine I. Brunner, Jordi Antón, Inmaculada Calvo‐Penadés, Richard Dimelow, Gerd Horneff, Sylvia Kamphuis, Rebecca Marino, Andre van Maurik, Kirsten Minden, Masaaki Mori, Josephine Ocran‐Appiah, Christel Wilkinson, Yuichi Yamasaki, Deepak Assudani, for the Pediatric Rheumatology Collaborative Study Group (PRCSG) and Paediatric Rheumatology International Trials Organisation (PRINTO) Network investigators   +14 more
wiley   +1 more source

Physical Exercise Improves Symptomatic Dermographism

Clinical and Translational Allergy
Background Short‐term exercise may reduce disease activity in symptomatic dermographism (SD), but its prevalence and short‐ and long‐term effects remain unclear and understudied.
Ragıp Ertaş, Muhammed Burak Yücel, Murat Türk, Şule Ketenci Ertaş, Emek Kocatürk, Melba Muñoz   +5 more
doaj   +1 more source

Evaluation of lipid profiles in patients with chronic spontaneous urticaria: A case-control study

Медицинская иммунология
Chronic urticaria is referred to recurrent, pruritic, erythematous, and edematous mucocutaneous lesions on most days of the week, and persists for six weeks or more.
Abbas Khalili, Fatemeh Azadi Talab Davoudabadi, Bamdad Sadeghi   +2 more
doaj   +1 more source

Infection focus as a potential cause of chronic urticaria – a case of a 12-year-old boy and the review of literature

Pediatria i Medycyna Rodzinna, 2019
Chronic urticaria is a rare disease in the paediatric population. It is characterised by the presence of blebs, angioedema or the coexistence of these changes for a period of more than 6 weeks.
Anna Góra, Majka Jaszczura, Małgorzata Morawiecka-Pietrzak, Edyta Machura   +3 more
doaj   +1 more source